Literature DB >> 9140319

Delayed administration of Vipera xanthina palaestinae antivenin.

Y Bentur1, F Zveibel, M Adler, B Raikhlin.   

Abstract

INTRODUCTION: Vipera xanthina palaestinae is the most widely distributed venomous snake in Israel, accounting for most envenomations. A specific equine antivenin is efficacious against both systemic and local manifestations if given within hours. This study sought to determine if delayed vipera xanthina palaestinae antivenin can be effective.
METHODS: Patients who had been bitten by vipera xanthina palaestinae during 1991-1995 were evaluated. Those who continued to deteriorate beyond 24 h post envenomation, in spite of treatment or because of delayed diagnosis, were given vipera xanthina palaestinae antivenin.
RESULTS: Ten patients were included in the study. Vipera xanthina palaestinae was identified in seven and diagnosis was considered probable in three patients. On admission, eight patients had local signs and seven patients had mild to severe systemic manifestations. The local signs were remarkable and progressive in all patients. In five, systemic signs and laboratory abnormalities were delayed as well. The time range for delayed antivenin administration was 1-6 days after envenomation. Following antivenin administration, progression of local signs ceased in all patients and swelling regressed within 24 h. In nine patients this occurred within 6 h.
CONCLUSION: Vipera xanthina palaestinae antivenin administration should be considered in patients with envenomations complicated by marked and progressive local signs, delayed systemic signs and laboratory abnormalities more than 24 h after envenomation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9140319     DOI: 10.3109/15563659709001209

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  5 in total

1.  Daboia (Vipera) palaestinae Envenomation in 123 Horses: Treatment and Efficacy of Antivenom Administration.

Authors:  Sharon Tirosh-Levy; Reut Solomovich-Manor; Judith Comte; Israel Nissan; Gila A Sutton; Annie Gabay; Emanuel Gazit; Amir Steinman
Journal:  Toxins (Basel)       Date:  2019-03-19       Impact factor: 4.546

2.  An assessment of medical students' proficiency in the diagnosis and management of snakebites: a cross-sectional study from Palestine.

Authors:  Suha S Sulaiman; Isra K Kharusha; Ahmad M Samara; Samah W Al-Jabi; Sa'ed H Zyoud
Journal:  J Occup Med Toxicol       Date:  2020-02-19       Impact factor: 2.646

3.  Assessment of Knowledge about First Aid Methods, Diagnosis, and Management of Snakebite among Nursing Students: A Cross-Sectional Study from Palestine.

Authors:  Isra K Kharusha; Suha S Sulaiman; Ahmad M Samara; Samah W Al-Jabi; Sa'ed H Zyoud
Journal:  Emerg Med Int       Date:  2020-12-16       Impact factor: 1.112

4.  Snakebites in Lebanon: A Descriptive Study of Snakebite Victims Treated at a Tertiary Care Center in Beirut, Lebanon.

Authors:  Tharwat El Zahran; Ziad Kazzi; Ahel Al-Hajj Chehadeh; Riyad Sadek; Mazen J El Sayed
Journal:  J Emerg Trauma Shock       Date:  2018 Apr-Jun

5.  A Genus-Wide Bioactivity Analysis of Daboia (Viperinae: Viperidae) Viper Venoms Reveals Widespread Variation in Haemotoxic Properties.

Authors:  Bianca Op den Brouw; Francisco C P Coimbra; Nicholas R Casewell; Syed Abid Ali; Freek J Vonk; Bryan G Fry
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.